紫鑫药业

紫鑫药业(002118)财务指标报告日期2011-06-302011-03-312010-12-312010-09-30每股指标摊薄每股收益(元)0.21720.25840.67510.3032加权每股收益(元)0.220.260.840.3每股收益_调整后(元)0.220.260.840.3扣除非经常性损益后的每股收益(元)0.22--0.850每股净资产_调整前(元)3.32026.46436.20592.3738每股净资产_调整后(元)3.326.466.212.37每股经营性现金流(元)0.41330.5649-0.83990.3252每股资本公积金(元)1.4113.82193.82190.1907每股未分配利润(元)0.82451.47291.21450.9959调整后的每股净资产(元)--------盈利能力总资产利润率(%)3.9512.3986.73994.3349主营业务利润率(%)60.197153.926154.158263.2523总资产净利润率(%)4.13512.485610.74085.9655成本费用利润率(%)45.966748.046637.605533.3259营业利润率(%)31.76933.362227.796625.6473主营业务成本率(%)38.847945.438245.133435.7809销售净利率(%)30.089533.136626.955324.1497股本报酬率(%)37.170125.842593.749330.3222净资产报酬率(%)11.19533.997715.106512.7736资产报酬率(%)6.76052.3989.35924.3349紫鑫药业(002118)财务指标销售毛利率(%)61.152154.561854.866664.2191三项费用比重()28.727423.363426.465338.6461非主营比重()3.94968.3912-1.10330.9308主营利润比重()191.0953161.6381199.1738251.7441股息发放率(%)--------投资收益率(%)--------主营业务利润(元)222941086.48107871329.02347921993.96164096055.66净资产收益率(%)6.54410.8812.77加权净资产收益率(%)6.76433.3513.6扣除非经常性损益后的净利润(元)112459528.25--176477838.570成长能力主营业务收入增长率(%)225.986523.2248150.662751.9785净利润增长率(%)325.0493465.9388183.486838.713净资产增长率(%)275.1192277.2258269.644218.2717总资产增长率(%)273.3397310.022292.1382121.8875营运能力应收账款周转率(次)2.30071.39594.84272.0109应收账款周转天数(天)156.4741257.898174.3387179.0243存货周转天数(天)342.0428596.0265126.3513181.6164存货周转率(次)1.05250.6042.84921.9822固定资产周转率(次)1.4631--2.5926--总资产周转率(次)0.13740.0750.39850.247总资产周转天数(天)2620.08734800903.38771457.4899流动资产周转率0.17510.09050.52940.3845紫鑫药业(002118)财务指标(次)流动资产周转天数(天)2055.9683977.9006680.0151936.2809股东权益周转率(次)0.22480.12310.63530.5633偿债及资本结构流动比率(%)1.89952.09382.16411.0899速动比率(%)1.80951.97791.98671.0233现金比率(%)127.6739150.1377144.395880.5989利息支付倍数()560.4787617.4577774.7187575.4785长期债务与营运资金比率(%)--------股东权益比率(%)60.387459.983361.954733.9368长期负债比率(%)--------股东权益与固定资产比率(%)684.186--618.6477--负债与所有者权益比率(%)65.597566.71361.4083194.6655长期资产与长期资金比率(%)--------资本化比率(%)--------固定资产净值率(%)75.8542--79.2675--资本固定化比率(%)41.222727.285528.791483.9502产权比率(%)65.477466.589761.2798193.3362清算价值比率(%)--------固定资产比重(%)8.8262--10.0145--资产负债率(%)39.612640.016738.045366.0632总资产(元)2820484639.672764209389.372569265077.051445279119.37现金流量经营现金净流量对销售收入比率(%)0.57250.7244-0.33530.259紫鑫药业(002118)财务指标资产的经营现金流量回报率(%)0.07520.0524-0.08380.0465经营现金净流量与净利润的比率(%)1.90262.1861-1.2441.0723经营现金净流量对负债比率(%)0.18980.131-0.22040.0704现金流量比率(%)19.011613.1243-22.08427.08492011-06-30杜邦分析净资产收益率6.54%总资产收益率3.951%X权益乘数1/(1-0.4)=资产总额/股东权益=1/（1-资产负债率）=1/（1-负债总额/资产总额）x100％主营业务利润率30.0895%X总资产周转率0.1374%=主营业务收入/平均资产总额=主营业务收入/(期末资产总额+期初资产总额)/2期末:2,820,480,000期初:2,570,378,806净利润111,442,000/主营业务收入370,352,000主营业务收入370,352,000/资产总额2,820,480,000主营业务收入370,352,000-全部成本253,802,960+其他利润120,860-所得税5,227,900流动资产+长期资产2,507,550主营业务成本147,410,660营业费用50,809,700管理费用30,247,000财务费用25,335,600货币资金短期投资应收账款存货其他流动资产411,308,000长期投资0固定资产0无形资产165,851,000其他资产-165,851,0002011-03-31杜邦分析净资产收益率4%总资产收益率2.398%X权益乘数1/(1-0.4)=资产总额/股东权益=1/（1-资产负债率）=1/（1-负债总额/资产总额）x100％主营业务利润率33.1366%X总资产周转率0.075%=主营业务收入/平均资产总额=主营业务收入/(期末资产总额+期初资产总额)/2期末:2,764,210,000期初:2,570,083,333净利润66,285,300/主营业务收入200,036,000主营业务收入200,036,000/资产总额2,764,210,000主营业务收入200,036,000-全部成本138,899,260+其他利润5,599,975-所得税451,415流动资产+长期资产1,779,470主营业务成本92,164,260营业费用22,076,800管理费用11,761,200财务费用12,897,000货币资金短期投资应收账款存货其他流动资产378,678,000长期投资0固定资产0无形资产167,172,000其他资产-167,172,0002010-12-31杜邦分析净资产收益率10.88%总资产收益率6.7399%X权益乘数1/(1-0.38)=资产总额/股东权益=1/（1-资产负债率）=1/（1-负债总额/资产总额）x100％主营业务利润率26.9553%X总资产周转率0.3985%=主营业务收入/平均资产总额=主营业务收入/(期末资产总额+期初资产总额)/2期末:2,569,270,000期初:654,905,659净利润173,174,000/主营业务收入642,417,000主营业务收入642,417,000/资产总额2,569,270,000主营业务收入642,417,000-全部成本464,513,260+其他利润-3,212,640-所得税1,517,100流动资产+长期资产1,779,470主营业务成本294,495,460营业费用101,350,000管理费用42,778,100财务费用25,889,700货币资金短期投资应收账款存货其他流动资产390,342,000长期投资0固定资产0无形资产168,478,000其他资产-168,478,0002010-09-30杜邦分析净资产收益率12.77%总资产收益率4.3349%X权益乘数1/(1-0.66)=资产总额/股东权益=1/（1-资产负债率）=1/（1-负债总额/资产总额）x100％主营业务利润率24.1497%X总资产周转率0.247%=主营业务收入/平均资产总额=主营业务收入/(期末资产总额+期初资产总额)/2期末:1,445,280,000期初:655,375,870净利润62,648,400/主营业务收入259,431,000主营业务收入259,431,000/资产总额1,445,280,000主营业务收入259,431,000-全部成本195,594,850+其他利润1,344,000-所得税2,531,750流动资产+长期资产1,555,000主营业务成本95,334,950营业费用66,451,600货币资金短期投资应收账款长期投资0固定资产0无形资产131,886,000管理费用20,099,200财务费用13,709,100存货其他流动资产74,237,700其他资产-131,886,0002010-06-30杜邦分析净资产收益率5.78%总资产收益率3.4703%X权益乘数1/(1-0.4)=资产总额/股东权益=1/（1-资产负债率）=1/（1-负债总额/资产总额）x100％主营业务利润率23.0767%X总资产周转率0.1611%=主营业务收入/平均资产总额=主营业务收入/(期末资产总额+期初资产总额)/2期末:755,474,000期初:654,954,305净利润26,220,800/主营业务收入113,610,000主营业务收入113,610,000/资产总额755,474,000主营业务收入113,610,000-全部成本88,173,960+其他利润-408,930-所得税-1,193,690流动资产+长期资产1,555,000主营业务成本28,461,660营业费用39,410,300管理费用14,501,100财务费用5,800,900货币资金短期投资应收账款存货其他流动资产96,430,900长期投资0固定资产0无形资产46,449,400其他资产-46,449,4002010-03-31杜邦分析净资产收益率2.67%总资产收益率1.7373%X权益乘数1/(1-0.35)=资产总额/股东权益=1/（1-资产负债率）=1/（1-负债总额/资产总额）x100％主营业务利润率36.4907%X总资产周转率0.0483%=主营业务收入/平均资产总额=主营业务收入/(期末资产总额+期初资产总额)/2期末:674,161,000期初:654,903,182净利润11,713,600/主营业务收入32,096,900主营业务收入32,096,900/资产总额674,161,000主营业务收入32,096,900-全部成本24